About Us

Lundbeck is a Global Pharmaceutical Company Specialized in Brain Diseases

We are tirelessly dedicated to restoring brain health, so every person can be their best. To fulfill this purpose, Lundbeck is engaged in the research, development, manufacturing, and commercialization of pharmaceuticals across the world. For more than 70 years, Lundbeck has been at the forefront of neuroscience research.

Our Commitment

Every day, we strive for improved treatment and a better life for people living with brain diseases – we call this Progress in Mind.

This is Lundbeck

One of the only pharmaceutical companies in the world focusing exclusively on brain diseases, recognized for having helped hundreds of millions of people with brain diseases.

research & development

LUPI has a strong tradition on process research and development, with approximately 35 reaction steps developed per year. Process Analytical Technology (PAT), Design of Experiments (DOE), process calorimetry, safety evaluation, impurity profile investigation and characterization are LUPI’s R&D main subjects.


As LUPI is responsible for the research and production of Active Pharmaceutical Ingredients (API), its Regulatory Affairs Department has been committed for many years to comply with all relevant Good Manufacturing Practices requirements from health authorities worldwide.

Product list

Active Ingredients are at the core of contemporary medicine. LUPI creates some of the most powerful elements of today’s pharmaceutical industry, ingredients that are used as antidepressants, antimalarial, antihypertensives, thrombin inhibitors, antiemetics, antiacne, and much more. 

At Lundbeck, we have a two-tier management structure consisting of our Board of Directors and Executive Management.

Corporate Governance

Our governance framework consists of rules and principles that support sustainable financial performance and long-term value creation for our shareholders and for our societies.